Cargando…

Inflammatory Breast Cancer from Metastatic Ovarian Cancer

Metastases to the breast from tumors other than breast carcinomas are extremely rare and represent only 0.2–1.3% of all diagnosed malignant breast tumors. Furthermore, while the most common sites for advanced ovarian cancer metastases are the liver, lung, and pleura, metastasis to the breast from a...

Descripción completa

Detalles Bibliográficos
Autores principales: Achariyapota, Vuthinun, Chuangsuwanich, Tuenjai, Benjapibal, Mongkol
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4800108/
https://www.ncbi.nlm.nih.gov/pubmed/27047697
http://dx.doi.org/10.1155/2016/3476143
_version_ 1782422433571012608
author Achariyapota, Vuthinun
Chuangsuwanich, Tuenjai
Benjapibal, Mongkol
author_facet Achariyapota, Vuthinun
Chuangsuwanich, Tuenjai
Benjapibal, Mongkol
author_sort Achariyapota, Vuthinun
collection PubMed
description Metastases to the breast from tumors other than breast carcinomas are extremely rare and represent only 0.2–1.3% of all diagnosed malignant breast tumors. Furthermore, while the most common sites for advanced ovarian cancer metastases are the liver, lung, and pleura, metastasis to the breast from a primary ovarian cancer is uncommon and has only been reported in 0.03–0.6% of all breast cancers. Here we describe a case report of a 50-year-old female patient with a rare case of breast metastases from an advanced ovarian cancer, presenting as inflammatory breast cancer. Our observations emphasize the clinical importance of distinguishing between primary and metastatic breast cancer during diagnosis for the purpose of appropriate prognosis and treatment.
format Online
Article
Text
id pubmed-4800108
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher Hindawi Publishing Corporation
record_format MEDLINE/PubMed
spelling pubmed-48001082016-04-04 Inflammatory Breast Cancer from Metastatic Ovarian Cancer Achariyapota, Vuthinun Chuangsuwanich, Tuenjai Benjapibal, Mongkol Case Rep Obstet Gynecol Case Report Metastases to the breast from tumors other than breast carcinomas are extremely rare and represent only 0.2–1.3% of all diagnosed malignant breast tumors. Furthermore, while the most common sites for advanced ovarian cancer metastases are the liver, lung, and pleura, metastasis to the breast from a primary ovarian cancer is uncommon and has only been reported in 0.03–0.6% of all breast cancers. Here we describe a case report of a 50-year-old female patient with a rare case of breast metastases from an advanced ovarian cancer, presenting as inflammatory breast cancer. Our observations emphasize the clinical importance of distinguishing between primary and metastatic breast cancer during diagnosis for the purpose of appropriate prognosis and treatment. Hindawi Publishing Corporation 2016 2016-03-07 /pmc/articles/PMC4800108/ /pubmed/27047697 http://dx.doi.org/10.1155/2016/3476143 Text en Copyright © 2016 Vuthinun Achariyapota et al. https://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Case Report
Achariyapota, Vuthinun
Chuangsuwanich, Tuenjai
Benjapibal, Mongkol
Inflammatory Breast Cancer from Metastatic Ovarian Cancer
title Inflammatory Breast Cancer from Metastatic Ovarian Cancer
title_full Inflammatory Breast Cancer from Metastatic Ovarian Cancer
title_fullStr Inflammatory Breast Cancer from Metastatic Ovarian Cancer
title_full_unstemmed Inflammatory Breast Cancer from Metastatic Ovarian Cancer
title_short Inflammatory Breast Cancer from Metastatic Ovarian Cancer
title_sort inflammatory breast cancer from metastatic ovarian cancer
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4800108/
https://www.ncbi.nlm.nih.gov/pubmed/27047697
http://dx.doi.org/10.1155/2016/3476143
work_keys_str_mv AT achariyapotavuthinun inflammatorybreastcancerfrommetastaticovariancancer
AT chuangsuwanichtuenjai inflammatorybreastcancerfrommetastaticovariancancer
AT benjapibalmongkol inflammatorybreastcancerfrommetastaticovariancancer